Adaptive designs for selecting drug combinations based on efficacy–toxicity response-Reference-Cited by-同舟云学术

Adaptive designs for selecting drug combinations based on efficacy–toxicity response

Published:2008-02 Issue:2 Volume:138 Page:352-373
ISSN:0378-3758
Container-title:Journal of Statistical Planning and Inference
language:en
Short-container-title:Journal of Statistical Planning and Inference

Author:

Dragalin Vladimir,Fedorov Valerii,Wu Yuehui

Publisher

Elsevier BV

Subject

Applied Mathematics,Statistics, Probability and Uncertainty,Statistics and Probability

Reference35 articles.

1. Multi-variate probit analysis;Ashford;Biometrics,1970

2. A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial;Bekele;Biometrics,2005

3. High-dimensional multivariate probit analysis;Bock;Biometrics,1996

4. Box, G.E.P., Hunter, W.G., 1963. Sequential design of experiments for nonlinear models. In: Proceedings of IBM Scientific Computing Symposium (Statistics).

5. The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes;Braun;Control. Clinical Trials,2002

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential optimal experimental design for vapor-liquid equilibrium modeling;Chemical Engineering Science;2024-12

2. Adaptive Seamless Dose-Finding Trials;Manufacturing & Service Operations Management;2024-09

3. An algorithm for computing generalized D-optimal allocation with cost consideration in regression models;Communications in Statistics - Simulation and Computation;2023-09-06

4. On dose-response modeling for evaluation of drugs combinations;Stochastic Analysis and Applications;2023-02

5. Bayesian Adaptive Designs for Phase I Trials;Principles and Practice of Clinical Trials;2022